Immunochemical studies of factor V of bovine platelets
- PMID: 7032911
- DOI: 10.1111/j.1432-1033.1981.tb05694.x
Immunochemical studies of factor V of bovine platelets
Abstract
Immunochemical techniques were employed to investigate the molecular properties of bovine platelet factor V. An antiserum prepared against purified factor V rapidly inactivated platelet factor V, indicating that platelet factor V is antigenically related to plasma factor V. A reaction of identity between factor V in plasma and purified factor V was documented by immunodiffusion against an antibody to platelet factor V. When platelet factor V was extracted with Triton X-100 in the presence of protease inhibitors and subjected to immunoelectrophoresis against the antiserum to plasma factor V, a single antigenic component migrating toward the anode was observed. In the absence of protease inhibitors, following release by collagen or solubilization, platelet factor V appeared close to the origin suggesting proteolytic alteration. Platelet factor V released by collagen or extracted with Triton X-100 was activated by thrombin 7.4-fold and 4.5-fold respectively, compared to a 17-fold activation of factor V in plasma under identical conditions. The ability of thrombin to activate platelet factor V as well as the close correspondence of factor V activity and antigen released by collagen indicates that the molecule is largely in the unactivated form after release. A single component of molecular weight 270 000 was seen when platelet factor V released by collagen was immunoprecipitated and subjected to dodecylsulphate gel electrophoresis. Factor V coagulant assays and immunoelectrophoresis of subcellular fractions showed that platelet factor V is localized primarily in the alpha granules. Platelet factor V appears to be similar to, if not identical with, plasma factor V by the criteria of immunologic identity, similar electrophoretic mobility and virtually identical molecular weights.
Similar articles
-
Biosynthesis of factor V in isolated guinea pig megakaryocytes.J Clin Invest. 1985 Feb;75(2):339-46. doi: 10.1172/JCI111706. J Clin Invest. 1985. PMID: 3973008 Free PMC article.
-
Kinetics of thrombin-induced release and activation of platelet factor V.Eur J Biochem. 1986 Jan 2;154(1):213-8. doi: 10.1111/j.1432-1033.1986.tb09381.x. Eur J Biochem. 1986. PMID: 2417835
-
Activation of coagulation factor V by a platelet protease.J Clin Invest. 1982 Nov;70(5):1092-100. doi: 10.1172/jci110697. J Clin Invest. 1982. PMID: 6752201 Free PMC article.
-
Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin.J Biol Chem. 1990 Oct 5;265(28):17132-40. J Biol Chem. 1990. PMID: 2211616
-
Acquired factor V inhibitors.Baillieres Clin Haematol. 1998 Jun;11(2):305-18. doi: 10.1016/s0950-3536(98)80050-4. Baillieres Clin Haematol. 1998. PMID: 10097809 Review.
Cited by
-
Biosynthesis of factor V in isolated guinea pig megakaryocytes.J Clin Invest. 1985 Feb;75(2):339-46. doi: 10.1172/JCI111706. J Clin Invest. 1985. PMID: 3973008 Free PMC article.
-
Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.J Clin Invest. 1984 Oct;74(4):1221-8. doi: 10.1172/JCI111531. J Clin Invest. 1984. PMID: 6480825 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources